ProCE Banner Activity

My Thoughts on Expanding the Role of PARP Inhibitors in Prostate Cancer With Combination Therapy

Clinical Thought
Here are my thoughts on some of the ongoing clinical trials of combination therapy approaches using PARP inhibitors in advanced prostate cancer.

Released: January 25, 2021

Expiration: January 24, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.